GNC’s quarterly earnings call scheduled for Wednesday morning has been postponed until after markets close on Nov. 9.
In a press release issued shortly after 4 p.m. Tuesday, the Pittsburgh-based health and wellness retailer said it is delaying the financial report as it continues “to work with Harbin Pharmaceutical Group Holding Co. Ltd toward completing their previously announced $300 million strategic investment” and joint venture with the Chinese company, also known as Hayao.
The proposed deal, which would give Hayao five seats on GNC’s expanded 11-member board of directors, was first announced in February.
It has since received approval form each company’s shareholders as well as regulatory approvals from both the U.S. and Chinese governments.
However, the agreement is still subject to clearing a foreign exchange registration requirement by China, “as well as final negotiation and execution of definitive documentation for the Chinese joint venture,” according to GNC’s release Tuesday.
While the vitamin retailer still expects the deal to close this year, “There can be no assurance that the remaining closing conditions will be satisfied or waived within that time frame,” the release said.
Read More
GNC shares closed at $3.90 Tuesday, up from $3.52 at Monday’s closing.
Steve Twedt: stwedt@post-gazette.com or 412-263-1963.




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.